Brief: Helix Biopharma Corp Receives U.S. FDA Approval For Pancreatic Trial
08/08/2019 24:57
Aug 7 (Reuters) - Helix Biopharma Corp HBP.TO :
* HELIX BIOPHARMA CORP. RECEIVES U.S. FDA APPROVAL FOR PHASE
IB/II
PANCREATIC TRIAL
Source text for Eikon: ID:nGNX3qmj2W
Further company coverage: HBP.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Helix Biopharma
See all newsBrief: Helix Biopharma Reports Q3 Loss Per Share C$0.02
Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
Brief: Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary
Brief: Helix Biopharma Says Expects To File Interim Disclosure Documents By July 30, 2020
Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020